 |
1 Product |  |
1 Disease | | 1 Product |
|
0 Trials |  |
3 News |  |
- ||| AK-3008 (bevacizumab biosimilar) / Aosaikang Pharma, Anhui Anke Biotech
New P1 trial: Pharmacokinetics and Safety Study of ASKB1202 in Chinese Healthy Subjects (clinicaltrials.gov) - Apr 13, 2017
P1, N=126, Not yet recruiting, Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd.